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p14ARF interacts with the focal adhesion kinase and protects
cells from anoikis
M Vivo, R Fontana, M Ranieri, G Capasso, T Angrisano, A Pollice, V Calabrò and G La Mantia
The ARF protein functions as an important sensor of hyper-proliferative stimuli restricting cell proliferation through both p53-
dependent and -independent pathways. Although to date the majority of studies on ARF have focused on its anti-proliferative role,
few studies have addressed whether ARF may also have pro-survival functions. Here we show for the ﬁrst time that during the
process of adhesion and spreading ARF re-localizes to sites of active actin polymerization and to focal adhesion points where it
interacts with the phosphorylated focal adhesion kinase. In line with its recruitment to focal adhesions, we observe that hampering
ARF function in cancer cells leads to gross defects in cytoskeleton organization resulting in apoptosis through a mechanism
dependent on the Death-Associated Protein Kinase. Our data uncover a novel function for p14ARF in protecting cells from anoikis
that may reﬂect its role in anchorage independence, a hallmark of malignant tumor cells.
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INTRODUCTION
The ARF protein functions as sensor of hyper-proliferative stimuli
restricting cell proliferation through both p53-dependent and
-independent pathways.1 In line with its tumor-suppressive role,
ARF-deﬁcient mice develop lymphomas, sarcomas and
adenocarcinomas.2 In humans, the importance of ARF inactivation
in cancer development is less clear and p16INK4a appears to have
a more relevant role in tumor protection.3 More than 30 distinct
ARF-interacting proteins have been identiﬁed, suggesting
that ARF is involved in a number of different cellular processes.4
Although ARF expression levels in normal proliferating cells
are very low, studies based on its loss have revealed its
importance in different physiological and developmental
mechanisms.5–8
Since its initial discovery, ARF has been described to have a
prevalent nucleo-nucleolar localization. More recently, ARF has
been reported to localize also in the cytoplasm mainly associated
to mitochondria, and also because of its role in autophagy.9
Despite its role in growth suppression, ARF is overexpressed in a
signiﬁcant fraction of human tumors.10 Increased expression of
p14ARF has been associated with progression and unfavorable
prognosis in hematological malignancies and in aggressive B-cell
lymphomas, and predicts a shortened lifespan.11 Furthermore,
recent ﬁndings suggest that ARF loss hampers, instead of
promoting, progression of prostate tumor,12 and in mouse
lymphomas displaying mutant p53, ARF has been described as
having a tumor-promoting activity correlated with its role in
autophagy.13 Interestingly, it has been reported that the p14ARF
protein level increases in thyroid cancer-derived tissues and,
remarkably, a delocalization to the cytoplasm has been observed
in some aggressive papillary carcinomas.14 Although in these
cancers ARF has been found to be wild-type, an ARF increase has
been explained as accumulation of non-functional protein.
Our previous data suggest that, following activation of protein
kinase C, ARF protein is phosphorylated and accumulates in the
cytoplasm where it appears unable to efﬁciently control cell
proliferation.15 These ﬁndings, together with the observations in
the cited literature, raise the possibility that ARF expression in
cancer cells could aid tumor progression by conferring unknown
pro-survival properties to the cells.
Here, we present data showing that during cell adhesion and
spreading, p14ARF is delocalized from nucleoli to sites of actin
polymerization concentrating at focal contacts where it colocalizes
with the focal adhesion kinase (FAK). Moreover, we show that ARF
depletion leads to defects in cell spreading and actin cytoskeleton
spatial organization in both tumor and immortalized cell lines.
Finally, we demonstrate that p14ARF can confer resistance to
death-associated protein kinase (DAPK)-dependent apoptosis.
RESULTS
ARF localizes to focal contacts during spreading
Cancer-derived HeLa cells express high levels of p14ARF, whereas
immortalized HaCaT keratinocytes express low levels of this
protein. Remarkably, in HaCaT cells ARF is mainly localized to the
cytoplasm.8 By immunoﬂuorescence analysis in HeLa and
HaCaT cells, we noticed that ARF accumulated at the edge of
cells, in particular to lamellipodia and ﬁlopodia where rapid actin
ﬁlament dynamics take place. We therefore examined ARF
localization during the process of cellular adhesion and spreading.
To synchronize and follow the adhesion process, HeLa cells were
detached from the plate by trypsinization, plated onto coverslips
and collected at different time points. We analyzed ARF
localization by IF (immunoﬂuorescence) while actin cytoskeleton
was visualized by tetramethylrhodamine-conjugated phalloidin
staining. Thirty minutes after plating, p14ARF was detected along
the plasma membrane, (Figure 1; 30 min). During spreading, ARF
protein localizes ﬁrst to cytoplasmic blebs and later on to ﬁlopodia
(Figures 1, 3 and 5 h after plating). This localization was observed
with two different ARF antibodies, and on transfected p14ARF,
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either tagged with GFP or not (Supplementary Figures S1a–c).
Similar results were obtained on cells plated within a three-
dimensional substrate such as Matrigel thus suggesting that this
localization does not depend on the speciﬁc substrate used for
adhesion (Supplementary Figure S2a). Immunoﬂuorescence stain-
ing of the nucleolar protein B23 showed that nucleoli were not
disassembled at any time after seeding (Supplementary
Figure S2b).
Figure 1. ARF localizes to the plasma membrane during adhesion/spreading process. HeLa cells were detached by gentle trypsin treatment,
re-suspended in growth medium and allowed to adhere onto ﬁbronectin-coated coverslip, and at various times following plating, rinsed in
PBS (4 °C) and ﬁxed with 3.75% PFA. Cells were ﬁxed at different time points after plating (30’, 1 h, 3 h and 5 h), permeabilized and subjected to
IF with anti-ARF antibody and both tetramethylrhodamine phalloidin and DAPI staining to visualize actin cytoskeleton and nuclei.
Representative images of ARF subcellular localization are shown for each time point. Images were taken with a Zeiss confocal laser-scanning
microscope LSM 510 (Oberkochen, Germany) (scale bar, 7μm). A 40 × objective was used and image analysis was performed using ImageJ.
Samples that were to be directly compared were imaged at the same sitting, and the same gain and exposure time were used. Histograms,
representing the mean of three independent experiments, reports the percentage of cells in which ARF localize with f-actin. For each time
point, 50 cells have been analyzed. S.d. are also shown. Asterisks (*) indicate statistically signiﬁcant differences by unpaired two-tailed t-test
with Welch correction: *Po0.001 between each point and 1-h time point.
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Cell interaction with the extracellular matrix results in integrin-
mediated tyrosine phosphorylation and recruitment of FAK to
focal adhesions.16,17 We thus monitored ARF localization during
spreading by following the localization of phosphorylated FAK
and of its target, such as Paxillin phosphorylated on Tyrosine 118.
Confocal analysis showed ARF/FAK and ARF/Paxillin colocalization
at focal adhesions 5 h post-seeding (Figures 2a and b, IF and
graph), while 24 h after seeding ARF was mainly localized to the
Figure 2. ARF interacts with active FAK during adhesion. ARF colocalizes with active FAK (phosphorylated FAK on Tyr397) and phosphorylated
Paxillin during adhesion. HeLa cells were allowed to adhere onto ﬁbronectin-coated coverslips for 5 and 24 h as described before, ﬁxed and
subjected to IF with anti-ARF and either pFAK Y397 antibody or pPaxillin Tyr118 antibody. Representative images showing ARF and pFAK (a) or
ARF and pPaxillin (b). Subcellular localization are shown for each time point. Images were taken as described before (scale bar, 10 μm).
Histograms below each panel, representing the mean of three independent experiments, reports the percentage of cells in which ARF
colocalize with pFAK or pPAXillin Tyr118. S.d. are also shown. Asterisks indicate statistically signiﬁcant differences (Po0.001) as described in
Figure 1. ARF and FAK co-immunoprecipitation. (c) Cytoplasmic HeLa extracts collected upon cell detachment (lanes 1–2), during spreading
(lanes 3–4), and 24 h after adhesion (lanes 5–6) were subjected to immunoprecipitation with anti-ARF antibody or IgG as negative control and
western blot with FAK and ARF antibodies. Inputs probed with anti-FAK antibody are shown. (d) Same experiment described in c performed
on HaCaT cells except that IB was performed with anti-pFAK Y397. Molecular weights of both ARF and FAK are shown on the left of each
western blot.
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nucleoli. We next performed co-immunoprecipitation experiments
of HeLa and HaCaT cytoplasmic extracts during cell spreading
(Figures 2c and d) with anti-ARF antibody followed by immuno-
blot with FAK antibodies. We detected an interaction between
p14ARF and FAK 5 h after plating (compare lane 4 with lane 2) that
was lost or reduced 24 h after plating (Figure 2c). Incubation with
anti-paxillin antibody did not show any interaction with ARF.
Reverse co-immunoprecipitation with anti-FAK antibody shows
interaction with both ARF and paxillin (Supplementary Figure S3).
The experiments thus suggest the existence of a time window
during spreading where a transient and speciﬁc ARF/FAK
interaction takes place at points of focal contacts.
ARF depletion induces actin cytoskeleton defects and decrease of
FAK levels
To analyze ARF role in cell spreading, we transiently transfected
cells with three different small interfering RNAs (siRNAs; siARF-1,
siARF-2 and siARF-3) targeting different regions of the unique
exon 1β of the INK4a/ARF locus (Supplementary Figure S4a). As
control, we found that p16INK4a levels were not signiﬁcantly
affected upon ARF silencing (Supplementary Figures S4a and b).
Control and ARF-depleted cells were then detached and re-plated
to follow the spreading process over time by phase-contrast
microscopy. Five hours after seeding, control cells were almost
completely spread, whereas ARF KD (Knock-Down) cells exhibited
a clear round morphology (Figure 3a and Supplementary
Figure S4c). The same effect was seen at 24 h after plating
(Figure 3a). Quantiﬁcation of spreading efﬁciency showed that less
than 50% of ARF-depleted cells were able to properly spread
(Figure 3b) As control, silencing of p16INK4a by RNA interference
does not affect cell morphology (Supplementary Figure S4d).
Staining with ﬂuorescein isothiocyanate-conjugated phalloidin
showed that ARF KD cells present blebs around the cell periphery
and rare or shorter ﬁlopodia (Figure 3c). Similar results were
obtained in both HeLa and HaCaT cells grown on Matrigel
(Supplementary Figures S5a and b)
As it was previously shown that defects in FAK phosphorylation
induces cells to acquire a round morphology,18,19 we analyzed the
levels of phospho-FAK in ARF-depleted cells by FAK immunopre-
cipitation and phospho-Tyr immunodetection in HeLa cells not
subjected to re-plating (Figure 4a, left panels), and upon
detachment and re-plating (Figure 4a, right panels). No signiﬁcant
change in FAK tyrosine phosphorylation occurred upon ARF KD
before re-plating. Instead, we found a decrease of FAK tyrosine
phosphorylation mirrored by total FAK levels reduction when ARF
KD cells were induced to spread. Quantitative reverse transcrip-
tase–PCR analysis showed no signiﬁcant change in FAK mRNA
levels upon ARF depletion, neither in the expression levels of
genes involved in cell adhesion such as ﬁbronectin, type IV
collagen and integrin β1 (Figure 4b). In agreement with this,
transfection of increasing amounts of ARF-expressing plasmid
induces an increase in the protein levels of FAK in HeLa cells
(Figure 4c). In addition to the 120 kDa FAK immunoreactive band,
slow migrating species, previously demonstrated to correspond
with SUMO-conjugated FAK forms,20 appear to be stabilized upon
ARF expression (Figure 4c, last lane). This is particularly evident in
HaCaT cells, where ARF overexpression induces a strong increase
of slow migrating FAK species (Figure 4d), and upon ARF and
SUMO co-transfection (Figure 4e) thus suggesting that ARF could
mediate FAK stabilization through sumoylation.21
ARF ectopic expression rescues both morphology and FAK
phosphorylation defects of ARF-depleted cells
To test if the effects of ARF silencing observed in HeLa cells were
strictly dependent on ARF, we performed a rescue experiment
transfecting both human and mouse ARF protein. Upon transfec-
tion with either an empty or an ARF-expressing vector, cells were
treated with scrambled or ARF-speciﬁc siRNA-1 for 48 h and then
induced to spread. Both p14ARF and p19ARF expression rescued
spread morphology defect caused by ARF silencing (Figure 5) thus
suggesting the existence of an evolutionary conserved mechan-
ism. In line with this, mouse protein also shows f-actin
co-localization during spreading (Supplementary Figure S6a).
To map ARF region responsible of this function, we performed a
rescue experiment by transfecting Hela cells with different ARF
deletion mutants corresponding to either aa 1–64, encoded by the
exon 1β, widely demonstrated to be necessary to elicit ARF cell
cycle arrest,22–24 or aa 65–132, encoded by the exon 2 (Figures 6a
and b). Transfected cells were treated with luciferase or ARF-speciﬁc
siRNA targeting the 5’-UTR region of endogenous transcript
(siARF-3). As both ARF mutants migrate with approximately the
same molecular weight of the endogenous protein, the silencing of
endogenous gene was checked in cells transfected with the empty
vector (data not shown). The evaluation of the spreading efﬁciency
(Figure 6c) clearly indicated that the ARF region encoded by exon 2
was able to rescue the spreading defect induced by depletion of
the endogenous protein. Regarding the exon 1β encoded domain,
we noticed that its expression per se (1–64 siSCR) impairs spreading
similarly to ARF depletion, and treatment with ARF siRNA (1–64
siARF) does not further affect cell spreading.
We next tested 65–132 mutant and p19ARF ability to rescue
FAK phosphorylation by FAK immunoprecipitation followed by
phospho-FAK immunodetection and observed that both proteins
restore normal levels of active FAK (Figure 6d and Supplementary
Figure S6b).
In order to map ARF domain required for ARF/FAK interaction
during spreading, either wt or ARF 65–132 deletion mutant were
transfected in HeLa cells and subjected to immunoprecipitation
(Figures 7a and b) with anti-ARF antibody. The 65–132 mutant
shows reduced pFAK binding (Figure 7b) thus suggesting that a
FAK-binding domain is present in the 1–64 amino-acid region. We
next analyzed binding efﬁciency of ARF 1–64 and of ARF 100–132
by immunoprecipitation with anti-GFP. Although ARF 100–132 is
still able to bind pFAK, the reduced binding shown by ARF 1–64
could reﬂect its impairment to induce FAK stabilization. We thus
probed the ﬁlter with antibody recognizing total FAK, thus
demonstrating that ARF 1–64 is still able to bind the FAK although
in a not phosphorylated form (Figure 7c).
We next analyzed the ability of these mutants to stabilize FAK,
by transfecting them in HeLa cells and evaluating pFAK levels
during spreading. We included in this analysis an ARF deletion
mutant devoid of 100–132 domain. The experiment shows that
only ARF 65–132 and ARF 100–132 are able to induce FAK
stabilization with an efﬁciency similar to the wt (Figure 7d).
Finally, we tested different ARF point mutants derived from
melanoma predisposing mutations25 affecting single residues
within an acidic motif (65–70 aa). We found that all of them are
still able to induce pFAK stabilization, at efﬁciency similar or higher
than the wt protein (Supplementary Figure S7). These experiments
collectively show that ARF binding to FAK is mediated by at least
two domains present in both the N-terminal and C-terminal
protein region. Moreover, binding is not sufﬁcient to induce FAK
stabilization and this function is restricted to the 100–132 amino-
acid region of p14ARF.
ARF depletion induces anoikis in HeLa and HaCaT cells
We next analyzed the relationship between cellular morphology
and viability of ARF-depleted HeLa cells. Apoptosis analysis, by
both western blot of PARP-1 cleavage and FACS-based Annexin V/
7-aminoactinomycin D (7-AAD) assay, shows that ARF silencing
induces 50% increase of the number of cells in apoptosis, as soon
as cells were induced to spread (Figure 8a). As round cells could
be easily separated from attached cells, we analyzed them
separately. The experiment shows that round cells are
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Figure 3. p14ARF depletion affects cell morphology. (a) Contrast images of HeLa cells transiently transfected with the indicated stealth siRNAs
for 48 h, detached by trypsinization and re-plated at a density of 1 × 105/ml in six-well plates. Images were collected and analyzed by phase-
contrast microscope 5 and 24 h after plating with a 20× objective (scale bar, 30 μm). (b) To quantify the percentage of each phenotype, for
each transfection point, we counted adherent and round cells in ﬁve different ﬁelds and pooled data from three to ﬁve experiments.
Spreading efﬁciency was measured by assaying the number of adherent cells relative on total cell number (graph). Cumulative data are
expressed as a mean value± s.e.m. of three independent experiments. Number of cells analyzed for each experiment: siSCR (200), siARF (200),
siLUC (200). Asterisks (*) indicate statistically signiﬁcant differences by unpaired two-tailed t-test between siARF and both siLUC and siSCR:
*Po0.0002, whereas NS indicates non statistical signiﬁcant values. (c) Confocal images of HeLa cells treated with control or speciﬁc ARF siRNA
for 48 h were left to adhere and doubly stained with ﬂuorescein isothiocyanate (FITC)-conjugated phalloidin and DAPI (scale bar, 10 μm).
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7-aminoactinomycin D/Annexin V-positive and showed increased
PARP-1 cleavage (Supplementary Figures S8c and d).
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay and crystal violet staining show that ARF silencing signiﬁcantly
reduced HeLa and HaCaT cell viability (Figures 8b and c).
To determine if apoptosis could be the cause of the so far
described spreading defect, ARF knockdown cells were treated
with the pan-caspase inhibitor Z-VAD-fmk. Quantiﬁcation of
spreading efﬁciency showed that apoptosis inhibition does not
rescue the morphology defect of ARF silenced cells (Figure 8d).
This could suggest that apoptosis could be induced in cells that
cannot properly spread. To explore this hypothesis, we analyzed
apoptosis in ARF-depleted HeLa cells grown in suspension as
spheroids by changing the coating vessel surface. After 48 h of
suspension culture, no PARP-1 cleavage was observed in control
and ARF-depleted cells (Figure 9a) even if spheroids were
disaggregated and cells re-placed under suspension culture
conditions for additional 24 h (Figure 9b, left panel). Conversely,
re-plating onto an adhesive substrate resulted in PARP-1 cleavage
(right panel) thus indicating that cell-substrate contacts are
required for apoptosis induction in cells devoid of ARF expression.
The DAPK, a pro-apoptotic serine/threonine kinase, is activated and
induces apoptosis following cytoskeleton–matrix disengagement.26,27
We thus investigated a possible involvement of DAPK in apoptosis
induced by ARF silencing. Simultaneous abrogation of ARF and DAPK
in HeLa and HaCaT cells by RNA interference rescues apoptosis
induced by ARF depletion (Figure 9c; Supplementary Figure S9a)
suggesting that ARF depletion induces anoikis through a DAPK-
Figure 4. ARF depletion affects FAK activation. (a) HeLa total extracts of ARF and control-depleted cells (adherent cells) were
immunoprecipitated with anti-total FAK antibody or with IgG as negative control and analyzed by western blot with anti-pTyr antibody
and subsequently with anti-t-FAK antibody cells before (left panels) or after adhesion following detachment and re-plating (right panels).
Panels of inputs probed with anti-FAK, ARF and actin antibodies are also shown on the left of each immunoprecipitation experiment.
(b) Quantitative reverse transcriptase (qRT)–PCR analyses of FAK, collagen IV, ﬁbronectin and integrin β1 mRNA levels normalized on G6PD
expression in cells treated with the indicated siRNA are shown. Cumulative data are expressed as a mean value± s.d. of three independent
experiments. Statistical analysis performed by unpaired, two-tailed Mann–Whitney test show no statistical (NS) difference between siSCR and
siARF samples. (c) HeLa and HaCaT cells were transfected with an empty vector (v) and increasing amount of p14ARF expression plasmid.
Twenty-four hours after transfection, cells were lysed and cellular extracts were immunoblotted and analyzed with anti-FAK, anti-ARF antibody
to detect exogenous ARF levels and anti-actin as loading control. (d and e) HaCaT cells were transfected with plasmids encoding ARF proteins
alone or in combination with plasmid encoding SUMO protein. Cellular extracts were analyzed as described before in b. Asterisks indicate
slow migrating FAK species. Western blots shown are representative of at least three independent experiments. Normalized FAK band
intensities are shown below each corresponding band, whereas sumo FAK are indicated on top above, and are expressed as fold enrichment
with respect to empty vector-transfected sample arbitrarily set to 1 (see Materials and Methods section for details).
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dependentmechanism.Moreover, both cell round phenotype and the
decrease of pFAK levels of ARF silenced cells were not affected by
DAPK abrogation, suggesting that were not caused by apoptosis
(Figure 9c, graph image and Supplementary Figure S9b). Interestingly,
upon ARF silencing a slight but reproducible increase of p53 levels
occurred both in HeLa, where the p53 pathway is not irreversibly
disabled,28 and HaCaT cells (Figure 9c and Supplementary Figure S9)
and is reversed by concomitant DAPK depletion.
Finally, rescue experiments with wt and mutant ARF expression
showed that both wt and ARF 100–132 are able to rescue cell
viability (Figure 9d) thus establishing a positive correlation
between increased pFAK levels and proliferation.
ARF depletion induces actin cytoskeleton defects but not anoikis
in H1299 cells
To get further inside on the role of ARF in cell spreading and FAK
phosphorylation, we extended our analysis to the H1299 cells,
expressing robust endogenous levels of p14ARF. Upon ARF
silencing, almost 50% cells failed to properly spread upon re-
plating until 24h after seeding (Figure 10a). Analysis of ARF
localization during adhesion and spreading by IF conﬁrmed ARF
recruitment at points of active actin polymerization in a time-
dependent manner (Figure 10b, 8 h after plating).
Interestingly, we found that, in contrast with what described
previously, FAK levels do not change upon ARF silencing
(Figure 11a). In line with this, no difference in FAK RNA levels
nor in other adhesion-related genes were found between ARF and
control-depleted cells (Figure 11b). These results suggest that the
spreading defect does not depend on FAK levels in these
experimental conditions. Consistently, transient FAK silencing in
HeLa cells does not completely phenocopy ARF depletion as cells
retain the ability to spread (Supplementary Figure S10a). These
experiments collectively show that in H1299 cells, the molecular
circuitry linking cytoskeleton dynamics and FAK levels are
Figure 5. Both human and mouse ARF transfections rescue cell spreading defect of p14ARF-depleted cells. HeLa cells transiently transfected
with empty, ﬂag-ARF or p19ARF vector for 24 h were treated with the indicated siRNAs for 48 h, detached and re-plated as described above.
(a) Western blot analysis with anti-Flag, ARF (human and mouse) and actin from collected cells. (b) Images of re-plated cells acquired by
phase-contrast microscope (scale bar, 30μm). (c) Cumulative data are expressed as a mean value± s.e.m. of at least three independent
experiments. Single experiment data have been tested as described in Materials and methods section to analyze normal distribution. Asterisks
(*) indicate statistically signiﬁcant differences by paired two-tailed Wilcoxon test. *Po0.001 and **Po0.01 by paired Student's t-test. Number
of cells analyzed for each experiment: SCR siRNA+ empty vector (350), ARF siRNA+empty vector (330), ARF siRNA+Flag-ARF (300), SCR siRNA+
Flag-ARF (350), SCR siRNA+p19ARF (336) and ARF siRNA+p19ARF (300).
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disconnected, thus implying that the round phenotype relies on
speciﬁc ARF-dependent functions.
Interestingly, when we analyzed the role of ARF on cell viability
in H1299, we found no effect on cell growth (Figure 11c).
Moreover, cellular growth curves showed that, although ARF is
required for proliferation of HeLa and HaCaT cells but it is
dispensable for H1299, all tested cell lines require FAK expression
to proliferate (Figure 11d and Supplementary Figure S10b). In
agreement, western blot analysis shows that FAK-depleted HeLa
and H1299 cells present PARP-1 cleavage and thus undergo
apoptosis (Supplementary Figure S10a and data not shown),
suggesting that, rather than having a role in spreading, FAK
downregulation is the signal that halts cell growth in these
cell lines.
We thus tested ARF ability to interact with FAK in this cell line.
Moreover, as neither p53 nor DAPK are expressed in these cells,
we tested if their exogenous expression could have a role in this
interaction. The experiment shows that ARF and FAK interact in
this cell line and the binding increases when DAPK is transfected
(Figure 12a). Interestingly, transient transfection of both wt and
DAPK K42A, a mutant defective in apoptosis induction, induce a
decrease in FAK levels (Figure 12b). We thus wondered if it could
be possible to induce apoptosis and FAK decrease upon ARF
silencing in H1299 cells following DAPK and p53 re-introduction
by transient transfection. As a key feature of apoptotic cell death is
genomic DNA fragmentation, we extracted genomic DNA and
analyzed its integrity by agarose gel electrophoresis. As expected,
ARF silencing does not affect genomic DNA integrity in this cell
line (Figure 13a). Transfection of p53 and wt DAPK slightly affect
genomic DNA integrity, whereas DAPK K42A is not functional.
Interestingly, ARF silencing further induces degradation of
genomic DNA in cells expressing either p53 or WT DAPK, even
more when both proteins are expressed, whereas it does not in
cells expressing the inactive DAPK K42A mutant. Cells transfected
with the DAPK constitutive active mutant (DAPK DCAM) strongly
show DNA degradation irrespective of ARF status. Analysis of pFAK
levels shows that ARF silencing has no effect of pFAK levels in
untransfected cells (Figures 13a and b). DAPK expression instead
induces a decrease of FAK expression when ARF is silenced
(Figure 13b, compare lane 4 with lane 3). Expression of
constitutive active DAPK DCAM strongly induces apoptosis and
decrease of FAK levels. This effect is further exacerbated when
cells are induced to spread (Figure 13c).
DISCUSSION
Here we show, for the ﬁrst time, that although in adherent cells
ARF localizes mainly in the nucleus, during the early phase of the
spreading process the protein is recruited or stabilized to cell
periphery at points of focal adhesions, in a precise time window.
This localization is substrate independent, and is involved in the
organization of actin structures during cell spreading. Reducing
ARF expression levels leads to defects in the spatial organization
of actin cytoskeleton during the process of cellular spreading. In
line with a role in this phenomenon, we noted that during cell
spreading ARF protein levels increase, through a protein kinase
Figure 6. Re-introduction of ARF exon 2 encoded domain in ARF-depleted cells restore both spreading and pFAK expression. Rescue
experiment was performed as described before, except that siRNA for the 5’-UTR of ARF gene was used (siRNA-3), and different ARF tagged
forms were tested. (a) Scheme of N-ter ﬂagged forms of ARF used in this study. (b) Immunoblot analysis of ﬂagged 14 ARF mutants and
tubulin (loading control) expression levels in whole-cell lysates of cells transfected and silenced with the indicated plasmids and siRNAs.
Asterisks indicate an aspeciﬁc ﬂag band. (c) Quantiﬁcation of spreading efﬁciency of cells. Data were quantiﬁed from three or more
experiments and 400 cells were analyzed for each transfection point in every experiment. Error bars represent the s.d. from the mean and
statistical analysis performed as described in Figure 5. *Po0.02 siARF-empty vector vs siSCR-empty vector; **Po0.0092 siARF-Flag-ARF vs
siARF-empty vector; ***Po0.0112 siARF-Flag 65–132 vs siARF-empty vector. (d) Analysis of pFAK and total FAK intracellular protein levels
upon rescue experiment by IP with anti-t-FAK antibody and IB with anti-pFAK Y397 antibody performed as previously described.
Representative western blots are shown. pFAK band intensities normalized versus t-FAK are shown below each corresponding band, and are
expressed as fold value with respect to empty vector siSCR-transfected sample, arbitrarily set to 1 (see Materials and Methods section for
details).
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C-dependent mechanism (Fontana, personal communication).
Interestingly, it has been reported that p19ARF-deﬁcient MEFs
display a round phenotype, similar to the one reported in our
study, accompanied by activation of the PI3K-Rac1 pathway and
increased migration properties.29,30 Despite signiﬁcant divergence
in amino-acid sequences, we show that this function is
evolutionary conserved and the expression of p19 per se increases
spreading efﬁciency (Figure 5c). In addition, our preliminary
experiments show that, in line with the aforementioned article,
ARF-depleted cells acquire increased migration properties.
Cell adhesion to the substrate is primarily mediated by integrins
that, connecting extracellular matrix with cytoskeleton, induce cell
survival pathways including phosphorylation and activation of
FAK,31,32 whose activation strongly correlates with tumor aggres-
siveness, cell migration and proliferation.33–35 Here we provide
evidence that p14ARF physically interacts with the FAK in its
Figure 7. (a) Scheme of N-ter EGFP tagged ARF constructs used in this study. (b) HeLa cells were transiently transfected with wt and ARF
65–132 mutants, and after 24 h cells were re-plated and cytoplasmic extracts immunoprecipitated with anti-ARF antibody and analyzed
by western blot with anti-pFAK Y397 and ARF antibodies. Panels of input are also shown on the right of immunoprecipitation experiment.
Bands corresponding to the immunoprecipitated protein were quantiﬁed with ImageJ and reported as percentage of input, quantiﬁed in the
same manner in order to obtain co-IP efﬁciency, indicated below the corresponding panel. (c) Cytoplasmic extracts of cells transfected
with empty vector, ARF 1–64 and ARF 100–132 were immunoprecipitated with anti-GFP antibody analyzed by western blot with anti-pFAK
Y397, t-FAK and GFP antibodies. Asterisk (*) indicates unspeciﬁc/degradation GFP products, arrow indicates immunoprecipitated FAK. Panel of
input is also shown on the right of immunoprecipitation experiment. Efﬁciency of co-IP is quantiﬁed as described in b. (d) Cytoplasmic
extracts were immunoprecipitated with anti-FAK antibody and analyzed by western blot with anti-pTyr antibody. Band intensity was
compared with wt ARF-transfected sample arbitrarily set to 1. Panels of input probed with anti-FAK, GFP and tubulin antibodies are
also shown.
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activated form. Given the observed reduction of total and
phosphorylated FAK during the cell spreading process in ARF-
depleted cells, we postulate that, through physical interaction, ARF
can exert a protective role on FAK upon detachment and
adhesion. Our experiments show that although the domains
necessary for FAK interaction are present both in the N-ter and
C-ter portion of the protein, the domain required for pFAK
stabilization is restricted to the exon 2 encoded region. It has to be
underlined that ARF region 100–132, required for both pFAK
activation and survival, has an established role in autophagy as
reported in Budina-Kolomets et al.36 thus suggesting that ARF
ability to regulate autophagy could be involved in this mechanism
and it is independent from the reported ARF functions in
mitochondrial homeostasis.25 However, from experiments per-
formed with mitotracker staining, we cannot exclude that ARF
localization to cell periphery during the early phases of cell
spreading (data not shown) could be in part mediated or primed
by mitochondria accumulation to sites of actin remodeling.
It has been reported that sumoylated FAK20 shows increased
stability compared with the un-modiﬁed counterpart (Kadare
et al.20 and our unpublished data), whereas ARF has been shown
to mediate sumoylation of its interacting partners.21,37 Our data
Figure 8. ARF depletion induces apoptosis. (a) HeLa cells were treated with the indicated siRNAs and analyzed by western blot 48 h later and
5 h and 24 h after plating. Silencing efﬁciency and viability was analyzed by western blot with anti-ARF and anti-PARP-1 antibody. Actin is a
loading control. The percentage of early apoptotic cells was quantiﬁed by FACS through PE Annexin V staining. Percentage of PE Annexin V+/
7-aminoactinomycin D-negative cells in siSCR and siARF-treated cells was reported in the graph. Cumulative data are expressed as a mean
value± s.d. of three independent experiments. Asterisk indicates statistically signiﬁcant differences by paired two-tailed Student's t-test with
Po0.05. (b) HeLa, HaCaT and as negative control, MCF-7 cells (bearing INK4a/ARF locus deletion) cells were transiently transfected with the
indicated siRNAs for 72 h. Silencing efﬁciency was analyzed by western blot with anti-ARF antibody. Actin is a loading control, whereas cell
viability was analyzed by a MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) based assay. The absorbance of each well (NT,
siSCR and siARF) is reported. Graphs represent mean values± s.d. of three independent experiments. Asterisks (*) indicate statistically
signiﬁcant differences with P-value obtained through the RM one-way ANOVA with the Greenhouse-Geisser correction *P = 0.0158,
**P= 0.0025. No statistical (NS) difference between samples are indicated. (c) HeLa, HaCaT and MCF-7 were transiently transfected with the
indicated siRNAs for 5 days, and cell viability analyzed by crystal violet staining of the plates (CVS assay). The absorbance of each well (NT,
siSCR and siARF) was calculated as percentage of the control wells (NT) set to 100%. Statistically signiﬁcant differences calculated as described
**P = 0.0002, *P= 0.0102. (d) HeLa cells were treated with control or speciﬁc ARF siRNA for 48 h and then re-plated in presence of the general
caspase inhibitor Z-VAD or DMSO as control for 5 h and analyzed by western blot to check silencing efﬁciency (left panel) and apoptosis
(middle panels) as described before and phase-contrast microscopy for analysis of cell morphology. Quantiﬁcation of percentage of cells with
round phenotype was performed as described before. Cumulative data are expressed as a mean value± s.d. of three independent
experiments. For each experiment, 100 cells were analyzed for each transfection point. Unpaired two-tailed t-test shows NS difference
between siARF DMSO and siARF Z-VAD-treated samples.
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show that ARF expression induces the appearance of slow migrating
FAK species, thus supporting the hypothesis that by interacting with
FAK it could mediate its sumoylation and stabilization.
Proper organization of cytoskeletal structures allows the
transduction of survival pathways inside the cells whose dereg-
ulation can result in anoikis.38–42 Resistance to anoikis is a hallmark
of malignant tumor cells, resulting in anchorage independence.
DAPK is an actin-associated pro-apoptotic protein having an
important role in tumor suppression43,44 and anoikis.26,45 Our data
show that cell death induced by ARF depletion is DAPK
dependent, as we observe anoikis rescue in doubly depleted
ARF/DAPK cells. It has been previously reported that DAPK can
phosphorylate ARF in vitro and thus promote p53-dependent
apoptosis.39 Recently, we have shown that phosphorylated ARF
species are more stable in the cytoplasm.46 As we noticed a
decrease of ARF protein levels upon DAPK silencing (see
Figure 8c), we speculate that DAPK could increase ARF stability
through phosphorylation, suggesting the existence of a feedback
loop between ARF and DAPK, in which ARF blocks DAPK-mediated
apoptosis during cytoskeleton remodeling, whereas DAPK exerts a
positive effect on ARF stability. Moreover, our data show an
increase of p53 protein levels and of its transcriptional targets
Puma and Apaf-1 (preliminary data not shown) upon ARF
depletion, suggesting that DAPK apoptosis induction could be in
part mediated through p53. Interestingly, it has been observed
that ARF expression in spermatogonia prevents p53-dependent
Figure 9. ARF depletion induces anoikis through a DAPK-dependent mechanism. (a) Western blot analysis of HeLa cells allowed to grow in
suspension as spheres for 24 h and treated with control and speciﬁc ARF siRNA for 48 h. (b) Spheres were disaggregated by gentle trypsin
treatment and re-placed in the same culture condition (b, left panels) or in adhesion (b, right panels) for 5 h. (c) HeLa cells grown in adherent
conditions were treated with control or ARF and DAPK-speciﬁc siRNA alone or simultaneously for 72 h. Cells were re-plated as already
described and analyzed by western blot analysis and phase-contrast microscopy. Silencing efﬁciency and vitality was analyzed by western blot
with anti-ARF and anti-PARP-1 antibody. Actin is a loading control. WB are representative of at least three independent experiments.
Normalized p53 band intensities are shown below respective wb panel, and are expressed as fold enrichment with respect to siSCR sample
arbitrarily set to 1 (see Materials and methods section for details). Round phenotype was quantiﬁed and reported in graph as described.
Cumulative data are expressed as a mean value± s.d. of three independent experiments. For each experiment, 100–150 cells were analyzed
for each transfection point. Analysis of variance show no statistical differences between the indicated values (NS) by paired two-tailed
Wilcoxon test P= 0.2. (d) HeLa cells were transiently transfected with ARF of mutant vector as indicated for 24 h and were treated with control
or ARF-3 siRNA (siUTR) for 72 h. Cell viability was analyzed by CVS (cristal violet staining) assay. The absorbance of each well treated with
siARF-3 was calculated as fold of the control wells (siSCR) set to 1. Graphs represent mean values± s.d. of two independent experiments.
Analysis of variance shows statistical signiﬁcant difference between empty vector and wt/mutant ARF-transfected points with P-valueo0.001
by Kruskal–Wallis test.
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apoptosis.47 Further experiments are needed to validate this
hypothesis.
It has been reported that overexpression of DAPK induces
morphological changes typical of apoptotic cells, such as cell
rounding and shrinkage.48 Our data only partially ﬁt with these
observations, as we do not observe a rescue of round phenotype
in DAPK-depleted cells. In line with these results, we observe that
H1299 cells, not expressing DAPK, show a round morphology
upon ARF depletion and result in anoikis resistance.
DAPK-mediated apoptosis is accompanied by a speciﬁc
decrease of FAK tyrosine phosphorylation.45 As in H1299 we do
not observe a decreased FAK activation upon ARF silencing, we
hypothesized that the FAK downregulation observed in HeLa and
HaCaT cells is at least in part due to activation of DAPK upon
ARF depletion. In line with this hypothesis, re-introduction
of both wt and death inactive DAPK mutant, induces a strong
decrease of FAK levels upon cytoskeleton remodeling. More
importantly, restoration of DAPK expression in H1299 cells induces
apoptosis and this effect is further ampliﬁed by concomitant ARF
silencing.
On this basis, we propose that, far from being simply inactive to
restrain cell growth, ARF confers pro-survival properties by helping
Figure 10. ARF is required for spreading and localizes to the plasma membrane of H1299 cells. (a) Contrast images of H1299 cells transiently
transfected with the indicated siRNAs for 48 h and 72 h treated as described in Figure 4 and analyzed by phase-contrast microscope 8 h after
plating, (scale bar, 30 μm). Quantiﬁcation of round phenotype was performed as described and is shown in the graph on the right. Cumulative
data are expressed as a mean value± s.e.m. of at least three independent experiments. For each experiment, 100–150 cells were analyzed for
each transfection point. Asterisks indicate statistically signiﬁcant differences between ARF and SCR treated cells with P-value obtained by
unpaired two-tailed t-testo0.05. (b) H1299 cells were detached, re-suspended in growth medium, allowed to adhere onto coverslips and
were ﬁxed at different time points after plating (1, 8 and 24 h). Permeabilized cells were subjected to IF with anti-ARF antibody and stained
with tetramethylrhodamine phalloidin to visualize actin cytoskeleton. Representative images showing ARF subcellular localization are shown
for each time point. Images were taken by Nikon ﬂuorescence microscopy (scale bar, 5 μm).
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cells to spread and protecting them from anoikis as illustrated in
Figure 14. This is accomplished through inhibition of DAPK-
induced apoptosis, and stabilization of FAK.
Conﬂicting data exist on ARF pro-oncogenic activity in some
experimental settings. In particular, it has been reported that ARF
contributes to prostate cancer progression by stabilization
through SUMO modiﬁcation of Slug protein.37 Moreover, the
ability of ARF to induce autophagy, a pro-survival mechanism
related to the phenomenon of tumor dormancy,49 also points to
the hypothesis that in particular cellular contexts ARF could have a
pro-proliferative or even oncogenic role. In this regard, it is
interesting to note that the effect of ARF loss on cell morphology
of prostate cells37 is the opposite of that observed in MEF cells and
in our experimental conditions.
Our ﬁndings point to a novel role of ARF on protection from cell
anoikis. This could have a strong impact on tumor growth and
dissemination. By providing insight into these previously unknown
functions of this protein, this study may have important
implications in development of novel strategies for cancer
therapy.
Figure 11. FAK levels and cell viability are unaffected by ARF depletion. (a) H1299 cells treated with control SCR and ARF-speciﬁc siRNA were
detached and induced to adhere. Total cell extracts (8 h after re-plating) were immunoprecipitated with anti-FAK antibody or with IgG as
negative control and analyzed by western blot with pFAK Y397 antibody and subsequently with anti-t-FAK antibody. Panels of inputs,
representative of three independent experiments, probed with anti-FAK, ARF and actin antibodies are also shown. (b) Quantitative reverse
transcriptase (qRT)–PCR analyses of FAK, collagen IV, ﬁbronectin and integrin β1 mRNA levels normalized on G6PD expression in cells treated
with the indicated siRNA are shown. Cumulative data are expressed as a mean value± s.d. of three independent experiments. Statistical
analysis has been performed as described in Figure 4. Not statistically signiﬁcant differences are indicated (NS). (c) H1299 cells were transiently
transfected with the indicated siRNAs and silencing efﬁciency analyzed by western blot with anti-ARF and actin as loading control. Viability
was checked with PARP-1 antibody, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and CVS (cristal violet staining) assay
as described previously. Data are expressed in c and d are mean value± s.d. of three independent experiments. (d) Growth curve of HeLa
and H1299 cells treated with the indicated siRNA at different time points. Asterisks indicate statistically signiﬁcant differences by
unpaired two-tailed t-test, between FAK and NC sirna treated cells **P= 0.0048, or between ARF and SCR sirna treated cells *P= 0.0085 for
HeLa cells. In H1299 cells, *P= 0.0217 between FAK and NC at 72 h and **P= 0.0002 at 96 h. Not statistically signiﬁcant differences are
indicated (NS).
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MATERIALS AND METHODS
HeLa cells were obtained from Dr Valeria R Villella, San Raffaele Scientiﬁc
Institute, Milan, Italy. All other cell lines (H1299, HaCaT and MCF-7) were
purchased from Cell Line Service (CLS, Eppelheim, Germany). Cells were
grown as described,15 transfected with Lipofectamine 2000, RNAiMAX
reagent or electroporation (Neon transfection System, Life Technologies
Carlsbad, CA, USA). Cells were routinely tested for mycoplasma contam-
ination and kept in culture for no more than 6 weeks.
ARF siRNAs (harboring the stealth modiﬁcation) anneal in the exon 1β of
p14ARF transcript. ARF and p16INK4a siRNA sequences has been reported
in Vivo et al.8 and Kobayashi et al.50 DAPK, FAK and luciferase siRNAs
are available by Qiagen (Hilden, Germany). All siRNA were transiently
transfected at a ﬁnal concentration of 10 μM, except siRNA-3 that was used
at 30 μM. Fibronectin puriﬁed from bovine plasma (Millipore, Billerica, MA,
USA; 10 μg/ml). Z-VAD fmk (BioVision, Milpitas, CA, USA) was used at ﬁnal
concentration of 10 μM.
Quantitative reverse transcriptase–PCR analysis
Equal number of cells was lysed with RNA Mini Kit Ambion (Carlsbad, CA,
USA). In all, 1 μg of total RNA of each sample was reverse-transcribed and
quantitative PCR ampliﬁcations were performed as described in Vivo et al.8
Primers were used: p16INK4a forward 5′-CCAACGCACCGAATAGTTACG-3′,
reverse 5′-GCGCTGCCCATCATCATG-3′. FAK, DAPK, collagen IV, ﬁbronectin
and integrin β1 primers were purchased from Qiagen (Quantitect Primer
Assay); G6PD forward 5′-ACAGAGTGAGCCCTTCTTCAA-3′ and reverse
5′-GGAGGCTGCATCATCGTACT-3′. Data presented represent the mean of
three biological replicates.
Western blot was performed as described.15 Band intensities were
quantiﬁed by ImageJ Software (free software, NIH), normalized to actin and
reported in graph as percentage of control. Each proﬁle represents the
mean of three independent experiments.
The list of antibodies are as follows: anti-PARP-1, (Cell Signaling Denvers,
MA, USA, #9542); anti-ARF C-18, anti-actin I-19, anti-p53 DO-1, anti-caspase-
3 H-277, anti-FAK C-20, anti-pFAK (Tyr397)-R for IF, (Santa Cruz
Biotechnology, Heidelberg, Germany), anti-pFAK (Tyr397) (BD Milan, Italy;
clone 14 for wb), anti-ARF Ab2 14PO2 (Neomarkers from Bio-Optica, Milan,
Italy); anti-p19ARF (Novus Biologicals from Novus Italy, Milan, Italy; Ab80)
anti-DAPK-55 mouse monoclonal antibody (Sigma Aldrich, Milan, Italy);
anti-pPaxillin Tyr118 (Life Technologies) and anti-pTyr 05-321 (Upstate
from Millipore, Darmstadt, Germany).
Cell viability assays. Cell viability was determined by the crystal violet
staining method51 or through a (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide)) MTT based assay.52 Dye uptake was measured at
580 nm using a spectrophotometer. Cell viability was calculated as dye
intensity and compared with untreated samples.
Microscopy and IF. Live phase-contrast images were acquired using a
(Nikon Eclipse microscope, Tokyo, Japan). Cell spreading was quantiﬁed as
described in Tamura et al.53 Fibronectin stimulation and IF were performed
as described in Schlaepfer and Hunter54 and Vivo et al.46 Cells were
incubated with Tetramethylrhodamine or ﬂuorescein isothiocyanate-
conjugated phalloidin for 30 min, followed by DAPI (Sigma-Aldrich) for
3 min and washed with PBS/0.05% Tween. Coverslip were mounted with
Ibidi mounting medium (Ibidi GmbH, Martinsried, Germany).
Immunoprecipitation assays were performed either with cytoplasmic
extracts or total cellular extracts (from 5× 106 cells per sample). Subcellular
fractionation was done as previously described.15 For total cellular extracts,
cells were harvested, lysed with RIPA buffer and incubated with anti-ARF
antibody (C-18 Santa Cruz Biotechnology) or anti-FAK antibody.
Apoptosis was analyzed by PE Annexin V Apoptosis Detection Kit I (BD
Biosciences; cat no. 559763) following the manufacturer’s instructions.
Figure 12. ARF interacts with FAK in H1299 cells. (a) H1299 cells were transiently transfected with empty vector (v) or either p53 or DAPK-
expressing plasmids. After 24 h, cells were re-plated and cytoplasmic extracts immunoprecipitated with anti-ARF antibody and analyzed by
western blot with anti-pFAK Y397, ARF and p53 antibodies. Panels of input are also shown on the right of immunoprecipitation experiment.
(b) H1299 cells were transfected with an empty vector (v) or increasing amount of wt DAPK or DAPK K42A expression plasmids. Twenty-four
hours after transfection, cells were lysed and cellular extracts were immunoblotted and analyzed with anti-FAK, anti-DAPK and anti-tubulin as
loading control. WB shown are representative of at least three independent experiments. Normalized FAK band intensities are shown below
each corresponding band, and are expressed as fold enrichment with respect to empty vector-transfected sample arbitrarily set to 1.
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DNA content analysis for detection of apoptotic cells was performed as
described.55
Statistic. Data presented in this work was derived from experiments
performed at least in triplicate (biological replicates), except when
differently stated. The sample size of each experimental point is reported
in the relative ﬁgure legend, as well as the speciﬁc statistical analysis
performed. In all the experiments in which single cells were analyzed, 5–10
ﬁelds were randomly selected in the coverslip for each experimental point.
Data have been analyzed to assay normal distribution with different tests,
such as the D’Agostino and Pearson omnibus, the Shapiro–Wilk and the KS
normality test. Analysis of data not showing a normal distribution were
performed with the Wilcoxon, Mann–Whitney tests and Kruskal–Wallis test,
otherwise t-test and analysis of variance were performed using GraphPad
Prism 5.0 software (La Jolla, CA, USA).
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